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ABSTRACT
The RAD54 family DNA translocases have sev-
eral biochemical activities. One activity, demon-
strated previously for the budding yeast translo-
cases, is ATPase-dependent disruption of RAD51-
dsDNA binding. This activity is thought to pro-
mote dissociation of RAD51 from heteroduplex DNA
following strand exchange during homologous re-
combination. In addition, previous experiments in
budding yeast have shown that the same activity
of Rad54 removes Rad51 from undamaged sites
on chromosomes; mutants lacking Rad54 accumu-
late nonrepair-associated complexes that can block
growth and lead to chromosome loss. Here, we show
that human RAD54 also promotes the dissociation
of RAD51 from dsDNA and not ssDNA. We also show
that translocase depletion in tumor cell lines leads to
the accumulation of RAD51 on chromosomes, form-
ing complexes that are not associated with mark-
ers of DNA damage. We further show that combined
depletion of RAD54L and RAD54B and/or artificial
induction of RAD51 overexpression blocks replica-
tion and promotes chromosome segregation defects.
These results support a model in which RAD54L and
RAD54B counteract genome-destabilizing effects of
direct binding of RAD51 to dsDNA in human tumor
cells. Thus, in addition to having genome-stabilizing
DNA repair activity, human RAD51 has genome-
destabilizing activity when expressed at high levels,
as is the case in many human tumors.
INTRODUCTION
The strand exchange protein RAD51 functions to promote
genome stability by repairing DNA double strand breaks
(DSB) and damaged replication forks (1–3). RAD51 repairs
damage by forming helical nucleoprotein filaments on tracts
of ssDNA. Such tracts form by 5′-3′ processing of DNA
ends formed by DSBs, and also as a consequence of replica-
tion fork collapse or blockage. The ssDNA-specific binding
protein RPA binds rapidly and with high specificity to ss-
DNA tracts and, with the help of mediator proteins, pro-
motes the recruitment of RAD51 (reviewed by (4)). Fol-
lowing nucleoprotein filament formation, RAD51 carries
out a search for homologous dsDNA sequences and then
promotes invasion of target duplex leading to the exchange
of DNA strands that forms heteroduplex DNA within an
intermediate called the displacement loop (D-loop). The
ssDNA strand displaced from the target duplex during
heteroduplex DNA formation also binds RPA (5). Subse-
quent stages of the recombination process result in repair of
damage without loss or rearrangement of DNA sequences.
RAD51 complexes engaged in repair can be detected by
immunostaining and light microscopy and are visualized
most often as foci, i.e. structures smaller than the resolu-
tion limit of light microscopy. RAD51 focus formation can
be induced by treatments that damageDNAor inhibit repli-
cation, and the majority of these damage-induced RAD51
foci co-localize with RPA.
Despite this central role in homology-mediated repair
and genome stabilization, high levels of RAD51 expres-
sion can result in reduced proliferation and increased ge-
nomic instability (6,7). Intriguingly, RAD51 is commonly
expressed at relatively high levels in human tumor cells com-
pared to noncancerous cells and the nuclei of these cells con-
tain elevated levels of spontaneous RAD51 foci compared
with nontumor cells (8–14). Increased spontaneousRAD51
nuclear foci were observed in cell lines derived from a wide
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variety of cancers including acute myeloid leukemia, T-cell
lymphoma, breast carcinoma and melanoma.
The RAD54 family of DNA translocase proteins func-
tion in concert with RAD51 to promote recombinational
DNA repair (reviewed by (15)). These proteins are mem-
bers of the Swi2/Snf2 family of motor proteins that utilize
energy from ATP hydrolysis to translocate on dsDNA, but
not ssDNA (16–20). Dissociation of RAD51 from dsDNA
is thought to be important to clear the 3′ ends of invading
ssDNAs of RAD51 during recombinational repair, thereby
allowing DNA polymerases to use 3′ ends as primers for
the DNA repair synthesis required to complete the repair
process (21). RAD54 translocation has also been proposed
to act following homology recognition as a ‘heteroduplex
pump’ to incorporate the invading ssDNA into the D-loop
while simultaneously removing RAD51 during the gener-
ation of the heteroduplex product (22). D-loop formation
is associated with local chromatin remodeling in vivo (23–
27) and biochemical data shows that RAD54 transloca-
tion displaces nucleosomes (28). Not only has RAD54 been
shown to remove RAD51 from dsDNA, it has also been re-
ported to stabilize the interaction of RAD51 with ssDNA
in vitro by a process that does not require ATP hydrolysis
(29). This activity can be observed by anti-RAD51 chro-
matin immunoprecipitation in vivo (30). Thus, RAD54 ap-
pears to contribute toDNA repair by stabilizing association
of RAD51 with ssDNA prior to RAD51-mediated strand
exchange and then disassembling RAD51 from the dsDNA
exchange product.
In addition to pro-recombinogenic activities of Rad54
family translocases, studies in budding yeast have shown
that the translocases prevent accumulation of nonrepair-
associated DNA bound forms of Rad51 and its meiosis-
specific paralog Dmc1 (31,32). In the absence of translo-
case activity, Rad51 accumulates on undamaged chromo-
somes causing growth arrest and chromosome loss (31).
The activity of Rad54 family translocase activity in remov-
ingRad51 from undamaged dsDNAprovides an interesting
contrast to the activities of other helicase/translocase pro-
teins such as FANCJ, FBH1, BLM or RECQ5, which re-
move RAD51 from ssDNA. This mechanism prevents ho-
mologous recombination in situations where such recombi-
nation is unnecessary and potentially detrimental (reviewed
by (33)).
Our studies on translocase function in budding yeast
raised the possibility that mammalian translocases,
RAD54L and RAD54B, could also function to prevent
the accumulation of nondamage-associated RAD51 com-
plexes. In mice, RAD54L and RAD54B deficiency or
expression of a dominant-negative RAD54 allele display
elevated levels of RAD51 foci on DNA (34,35). This
elevation in spontaneous RAD51 foci was interpreted as
resulting from defective repair at sites of DNA damage.
However, our results from budding yeast led us to hy-
pothesize that at least some of these spontaneous RAD51
foci might represent nondamage-associated complexes
resulting from an imbalance between RAD51 and RAD54
translocase activity.
The accumulation of RAD51 on undamaged DNA has
important implications for cancer etiology. RAD51 steady-
state levels are elevated in a wide variety of tumor cells.
The tumor cells may be susceptible to toxic accumulation of
RAD51, if high levels of RAD51 result in an imbalance of
RAD51 and RAD54 activity. We previously showed that a
compound called RS-1, which enhances binding of RAD51
to DNA, causes accumulation of nondamage-associated
RAD51 complexes and cell death (36). We also showed
that depletion of RAD54 translocases sensitized cells to
RS-1 treatment. However, it was not determined if human
translocases function to suppress RAD51 accumulation on
undamaged DNA.
Here we demonstrate that RAD54 translocase depletion
and/or RAD51 overexpression in human tumor cells re-
sults in the accumulation of RAD51 foci that do not co-
localize with markers of DNA damage. Accumulation of
these foci is associated with interruptions in replication, de-
fective chromosome segregation and reduced proliferation.
We also show that RAD54 protein dissociates RAD51 from
dsDNA, but not ssDNA, using purified protein, as shown
previously for the yeast ortholog. Given that many human
tumor cells express unusually high levels of RAD51, the re-
sults have potential implications with respect to both the
mechanism of tumor progression and cancer therapy.
MATERIALS AND METHODS
siRNA transfection conditions, determination of RAD51
cellular concentration, RAD51 DNA-binding assay,
RAD51 displacement assay and antibodies used in this
study are described in Supplementary Materials.
Cell culture
HT1080 (S33) cells were cultured in DMEM (Invit-
rogen) supplemented with 10% fetal bovine serum, 1
mM sodium pyruvate, 4× nonessential amino acids,
1× penicillin/streptomycin, 100 g/ml G418, 50 g/ml
hygromycin B and 5 ng/ml doxycycline. MCF7 and
MDAMB231 cells were cultured inDMEMcontaining 10%
fetal bovine serum and 1× penicillin/streptomycin. PC-3
cells were cultured in DMEM/F12 supplemented with 10%
fetal bovine serum. Cells were cultured at 37◦C with 5%
CO2. Wild-type and Rad54l-/-Rad54b -/- mouse embry-
onic stem cells (35) were cultured on gelatin-coated dishes
in GMEM media (Sigma) supplemented with 15% Em-
bryoMax FBS (Clontech), 4× nonessential amino acids,
1× penicillin/streptomycin, 1 mM sodium pyruvate, 2 mM
L-glutamine, 50 mM 2-mercaptoethanol and 1000 U/ml
leukemia inhibitory factor (LIF).
Western analysis
Western analysis of RAD51 was done as previously de-
scribed (36).
Immunofluorescence
Detection of proteins by immunofluorescence was done as
previously described (36) with the following changes. Cy-
tosolic proteins were pre-extracted with HEPES/Triton X-
100 buffer (20 mMHEPES pH 7.4, 0.5% Tritron X-100, 50
mM NaCl, 3 mM MgCl2, 300 mM sucrose) prior to fixa-
tion in 3% para-formaldehyde, 3.4% sucrose in ddH2O, pH
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7.0 for 10 min at room temperature. For the DNase experi-
ments, cells were incubated with 15 g/ml DNaseI in 0.2%
Triton X-100, 200 mM PIPES pH 6.8, 1 mMMgCl2 for 60
min at room temperature prior to fixation. Cells were irradi-
ated with 6 Gy ionizing radiation 6 h prior to fixation using
aMaxitron generator. To image cells, 0.5–1 micron sections
of the cells were acquired on a scanning laser microscope
(LSM510, Zeiss) using LSM software with a 60× objec-
tive. Previous studies examining spontaneous RAD51 foci
observed cells containing >10 discrete foci as well as cells
with fewer, but larger foci (14). To encompass both classes
of RAD51 foci, cells containing ≥ five discrete foci were
considered focus positive. Brightness and contrast were ad-
justed using ImageJ. Total cellular fluorescence= integrated
density - (area of interest X mean background level) (37).
For RAD51 fiber quantitation, RAD51 fibers were counted
in z slices separated by one micron to minimize the number
long fibers that transverse more than one slice. The number
of RAD51 fibers is the sum of fibers from z slices. In S33
cells, RAD51 and RPA foci were quantitated from 50 nuclei
from two independent experiments. InMCF7 cells, RAD51
andRPA foci were quantitated from 100 nuclei from two in-
dependent experiments. For experiments examining mitotic
defects, 50 nuclei from two independent experiments were
examined in both MCF7 and S33 cells.
Nuclear abnormalities
Nuclei stained with DAPI were examined for nuclear aber-
rations. Cells were examined for the presence of micronuclei
and DNA bridges. Multinucleated cells were cells contain-
ing more than one large nuclear staining body as well as
cells with amultilobed staining body. In S33, 50 random nu-
clei from two independent experiments were examined for
nuclear anomalies. To determine if the more severe nuclear
aberrations were present in a low percentage ofMCF7 cells,
300 nuclei from three independent experiments were exam-
ined.
EdU growth assay
At the indicated times post-transfection, EdUwas added to
the culturemedia to a final concentration of 10Mand cells
were stained for EdUas permanufacturer’s instructions (In-
vitrogen, Click-IT). Images were acquired using a Zeiss Ax-
iovision epifluorescence microscope at 100X magnification.
EdU staining was quantitated from 150 nuclei from three
independent experiments in S33 and MCF7 cells.
Nascent DNA assay
DNA fibers were prepared and immunostained as previ-
ously described (38). Images were acquired using a Zeiss
Axiovision epifluorescence microscope at 100X magnifica-
tion. The lengths of IdU (red) and CldU (green) tracts were
measured using ImageJ software. At least 250 fibers were
measured for each experimental condition.
Statistical analyses
For focus counts and CldU/IdU replication tract experi-
ments, P-values were calculated using Wilcoxon Rank Sum
Test. For EdU incorporation and chromosome segregation,
P-values were calculated using the F-test.
RESULTS
RAD51 overexpression results in the accumulation of DNA-
associated RAD51 complexes
To characterize the nuclear localization of RAD51, we be-
ganwith the S33 cell line, a derivative of the human fibrosar-
coma line HT1080 that carries an untagged RAD51 expres-
sion construct under the control of a doxycycline (dox)-
repressible promoter (6). Growth of S33 cells in media con-
taining 5 ng/ml dox maintains relatively low RAD51 ex-
pression; removal of dox increases RAD51 protein level 60-
fold from 0.06 to 4 M (Supplementary Figure S1a). Pre-
vious studies showed that induction of RAD51 in S33 re-
duces proliferation and results in formation of elongated
RAD51 fibers (6). We extended these findings using an im-
munostaining method that extracts soluble nuclear protein,
leaving only insoluble protein, including protein bound to
chromosomes (39). Removal of dox (i.e. overexpression of
RAD51) resulted in an increase in both the number of
RAD51 complexes/nucleus from 11 ± 3 RAD51 foci per
focus-positive cell (defined as> five foci) to 150± 53 and the
lengths of these structures from less than the resolution limit
(∼0.2m) to 1.2± 0.7m (Figure 1a). In 8%of nuclei, fiber
formation was even more extensive, with neighboring fibers
usually intersecting in Z-axis projections (Figure 1b). Inter-
estingly, RAD51 fibers appeared to be excluded from nu-
cleoli, which were visualized as DAPI-negative subnuclear
regions (Figure 1b). Importantly, DNase I treatment of
RAD51 overexpressing cells reduced the number of RAD51
fibers over 8-fold to 18 ± 21 (Figure 1a,d). DNase treat-
ment also caused a dramatic loss in staining for the repli-
some clamp protein PCNA, which binds dsDNA. In con-
trast, DNase treatment did not alter the staining pattern of
the nuclear matrix protein Lamin B, a protein that does not
associate with DNA (Supplementary Figure S2a) (40,41).
These results indicate that RAD51 fibers that form as a con-
sequence of overexpression represent aDNAbound formof
the protein. Another observation indicating association of
the fibers with DNA was detection of thin DNA-staining
threads (bridges) connecting two adjacent nuclei. RAD51
localizes to the contour of these DNA threads, a staining
pattern strongly suggesting that fibers are bound to DNA
(Figure 1b and Supplementary Figure S2c, see also Figure
6a below).
DNA bridges can arise as a result of catenated DNA per-
sisting through anaphase. Previous studies have shown that
the centromere protein, PICH, localizes to catenated DNA
(42). We examined localization of PICH on DNA bridges
in RAD51 overexpressing cells. We observed PICH stain-
ing DNA bridges in approximately 52 ± 9% of nuclei (Sup-
plementary Figure S2b). In 60% of PICH-positive DNA
bridges, PICH was localized only on a fraction of the DNA
bridge. No DNA bridges between interphase nuclei were
observed in cells cultured in the presence of dox (data not
shown). Thus, at least a subset of DNA bridges are likely to
arise due to the failure to resolve catenated DNA.
Previous studies did not determine whether or not
RAD51 fibers induced by RAD51 overexpression are as-
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Figure 1. RAD54 translocase depletion increases RAD51 complex formation in S33 cells overexpressing RAD51. (a) Representative images of S33 cells
after the indicated treatments. RAD51 (green), RPA (Red), DNA (blue). RAD51 staining in RPA-negative cells (columns 1 and 3) and RPA-positive cells
(unirradiated columns 2 and 4, irradiated columns 5 and 6). RAD51 staining in RPA-negative cells (columns 7 and 9) and RPA-positive cells (unirradiated
columns 8 and 10, irradiated columns 11 and 12) or after treatment with DNase I (column 13) in cells overexpressing RAD51. (b) Representative images
of a nucleus containing extensive RAD51 fibers. A DAPI staining thread that connects two nuclei and co-localizes with a RAD51 fiber is marked with an
arrow and nucleoli are indicated with asterisks. (c) Graph depicts fraction of cells that were RAD51 and/or RPA focus positive. Error bars, S.E. (d) Dot
plots depicting the number of RAD51 foci in RAD51 focus-positive cells/RPA-positive cells cultured in the presence of dox (left) or the number RAD51
fibers in cells cultured in the absence of dox (right). Red line and numbers above the graph represents mean focus counts. The percentage of the population
that was RAD51 focus-positive is depicted below the graph. (e) Dot plot depicting number of RPA foci in RPA-focus positive nuclei after the indicated
treatments. The percentage of the population containing S-phase RPA staining patterns is indicated below the graph. NS, nonsilencing. Scale bars, 10 m.
sociated with tracts of ssDNA, as would be expected if the
fibers were assembled at sites of damage. To address this,
S33 cells were co-stained with antibodies against RAD51
and the ssDNA binding protein, RPA. In unperturbed S
phase cells, RPA displays a characteristic staining pattern
comprising domains of relatively bright staining on a back-
ground of diffuse staining of intermediate intensity; RPA
staining is minimal or absent in G2, M and G1-phases
(43–45). Following induction of replication stress or DNA
breaks, RPA is redistributed within S-phase cells forming a
punctate pattern (46,47).
We performed RPA-RAD51 double staining in S33
cells with or without induction of RAD51 overexpres-
sion. RAD51 overexpression induced a similar level of
RAD51 foci in cells with extensive RPA staining (150 ± 56
RAD51 foci/nucleus) and in cells that contained little or no
RPA staining (151 ± 52 RAD51 foci/nucleus). (NB: RPA
staining-negative cells were defined as those with less than
five RPA staining foci with no diffuse background pattern.)
The RPA staining-positive cells displayed the punctate pat-
tern typically observed after replication stress orDNAdam-
age (Figure 1a,c,e) rather than themore diffuse S-phase pat-
tern observed in control cells. Only 35 ± 6% of RAD51
fiber-containing nuclei were RPA staining-positive. Thus,
in more than half of the cells, extensive RAD51 foci and
fibers accumulate without associated RPA foci. These data
strongly suggest that overexpression of RAD51 can cause
accumulation of RAD51 foci at sites that do not contain ss-
DNA. Within the RPA-positive subpopulation, induction
of RAD51 overexpression was associated with redistribu-
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tion of RPA from the diffuse staining pattern to punctate
foci, suggesting that either RAD51 fibers initiate directly
on ssDNA at replication forks or that they form on un-
damaged dsDNA, with subsequent local accumulation of
RPA foci as a consequence of replisome collisions with pre-
formed RAD51 fibers. We favor the latter possibility be-
cause, as mentioned above, RAD51 fibers were present in
similar numbers in both RPA-positive and RPA-negative
cells. It should also be noted that treatments which block
DNA polymerase activity cause a similar conversion of
RPA staining patterns (46,48,49).
Translocase depletion enhances accumulation of RAD51
complexes in S33 cells overexpressing RAD51
Previous studies in budding yeast showed that RAD54
translocases function to limit the accumulation of
nondamage-associated RAD51 foci (31). To determine if
RAD54 translocase activity limits RAD51 fiber accumu-
lation in S33 cells, we depleted RAD54L and RAD54B,
by 5- and 10-fold respectively, using RNA interference
(Supplementary Figure S1 b–g). We examined RAD51
and RPA localization in RAD54L+RAD54B translocase-
depleted cells, with or without concurrent overexpression
of RAD51. Control cells were transfected with nonsilenc-
ing (NS) siRNAs. At lower levels of RAD51 expression,
S-phase cells showed a modest 1.5-fold increase in RAD51
foci that was significant when analyzed by the Wilcoxon
Rank Sum Test (17 ± 10 versus 11 ± 3, respectively; Fig-
ure 1a,d; P < 0.005). Thus, RAD54L+RAD54B may limit
the number of spontaneous RAD51 foci during S-phase in
S33 cells, even without forced overexpression of RAD51.
No significant change was detected in non-S-phase cells.
In S33 cells induced to overexpress RAD51,
RAD54L+RAD54B depletion increased RAD51 fiber
formation containing on average 265 ± 121 RAD51
fibers compared to 150 ± 53 in controls (Figure 1a,d;
P < 0.001). The fluorescence intensity of DNA-bound
RAD51 provided an alternative method to measure the
extent of RAD51 complexes. RAD54L+RAD54B deple-
tion resulted in a 2.6-fold increase in RAD51 staining
intensity when compared to controls (P < 0.005; Supple-
mentary Figure S3a). We verified this result by depleting
RAD54L+RAD54B with a second, independent set of
siRNAs (Supplementary Figure S1c, siRAD54L+B-2).
RAD54L+B-2 depleted cells contained 222 ± 75 RAD51
fibers on average compared to 109 ± 57 fibers in controls
(Supplementary Figure S3d; P < 0.001). These results
indicate that the extent of accumulation of RAD51 fibers
following RAD51 overexpression is limited by RAD54
translocases. RAD54L+RAD54B depletion had no impact
on steady-state RAD51 levels (Supplementary Figure S1a)
indicating that the associated increase in RAD51 fibers
resulted from a redistribution of RAD51 in the nucleus.
Next, we determined if these changes in RAD51 focus
patterns require depletion of both translocases. Transfec-
tion with siRAD54L or siRAD54B did not increase the
number of RAD51 fibers; counts were 154 ± 88 and 142 ±
44 foci/nucleus for siRAD54L or siRAD54B, respectively,
compared to 153 ± 86 in controls (Supplementary Figure
S3b). However, RAD51 fiber length increased from 1.0 ±
0.7 m in controls to 1.6 ± 0.7 m and 1.8 ± 0.6 m
in siRAD54L and siRAD54B transfected cells, respectively
(P < 0.01 and P < 0.001). These results indicate that the
two translocases share a function that limits the accumula-
tion of RAD51 on DNA in S33 cells expressing high levels
of RAD51. The increase in fiber length, but not number,
caused by single translocase depletion may indicate that the
residual translocase activity in this situation is sufficient to
dissociate RAD51–DNA complexes as they initiate, but not
sufficient to fully limit fiber elongation.
The results of RPA-RAD51 double staining experiments
suggest that RAD51 fibers formed following RAD51 over-
expression and/or translocase inhibition are not associated
with RPA. To show that very high levels of RAD51 ex-
pression do not prevent RPA from forming foci on tracts
of ssDNA, we induced such tracts with ionizing radia-
tion and monitored focus induction. Importantly, irradia-
tion increased the fraction of nuclei displaying focal RPA
staining patterns 1.6- to 2.6-fold, regardless of RAD51 or
RAD54L+RAD54B levels (Figure 1c,e). In cells with lower
levels of RAD51, 65–80% of RAD51 foci co-localized with
RPA. Although the density of RAD51 fibers precluded
accurate estimates of the frequency of RAD51/RPA co-
localization, the fraction of RAD51-filament containing
nuclei that also containRPA foci was 2-fold higher than that
seen for corresponding conditions without irradiation (Fig-
ure 1c,e). This indicates that many unirradiated cells that
display RAD51 fibers, but not RPA foci, have the ability to
form RPA foci upon induction of DNA damage. Thus, the
induction of multiple RAD51 fibers in RPA focus-negative
cells by translocase depletion implies that these structures
form at sites lacking ssDNA tracts.
RAD54 family translocases prevent accumulation of
nondamage-associated RAD51 complexes in MCF7 cells
RAD51 levels are elevated in awide variety of human tumor
cell lines when compared to nontransformed primary cell
lines (8–14). Intriguingly, many tumor lines with elevated
RAD51 display spontaneous RAD51 foci (14). Given our
results using artificial induction of high levels of RAD51 in
S33 cells, we reasoned that spontaneous RAD51 foci ob-
served in other tumor lines might involve binding of the
protein to undamaged DNA. We predicted that these cell
lines harbor a propensity for RAD51 accumulation that
exceeds the cell’s ability to remove aberrant RAD51 com-
plexes, i.e. that translocase activity is limiting in these cell
lines. If so, reduction of translocase activity would increase
the frequency of these RAD51 foci, and generate associ-
ated toxicity.We tested this hypothesis in themammary car-
cinoma cell line MCF7, which displays relatively high lev-
els of spontaneous RAD51 foci (14). As expected, translo-
case depletion in MCF7 resulted in a striking increase in
RAD51 foci without increasing RPA staining (Figure 2). In
RPA-negative cells, the fraction of RAD51 focus-positive
cells was 15-fold higher in translocase-depleted compared
to control cells (31 ± 5% versus 2 ± 2%, P < 0.0005) with
an average of 7 ± 3 RAD51 foci/nucleus compared to 1 ±
2 RAD51 foci in controls (Figure 2c,d). A small fraction of
the RAD51 structures that accumulated following translo-
case depletion appeared as fibers (Figure 2b). RAD51 fo-
Nucleic Acids Research, 2015, Vol. 43, No. 6 3185
Figure 2. RAD54 translocase depletion increases RAD51 focus formation in MCF7 cells. (a) Representative images of nuclei after indicated treatments.
Staining was carried out as described in legend to Figure 1. Images depict non-S phase nuclei (columns 1 and 3) and RPA-positive (S-phase) nuclei
(unirradiated columns 2 and 4, irradiated columns 5 and 6). (b) Representative nuclei containing elongated RAD51 staining structures. (c) Graph depicts
fraction of the cell population that was RAD51 and/or RPA focus positive. (d)Dot plot depicting number of RAD51 foci in MCF7 cells. The plot depicts
RAD51 focus counts among the non-S phase (RPA-negative) cells. The percentage of the population that was RAD51 focus-positive/RPA-focus negative
is depicted below the graph. Red line and numbers above the graph represent the mean RAD51 focus counts. (e) Dot plot depicting RAD51 focus counts
in RPA-positive cells in unirradiated cells and irradiated cells as in Figure 1. (f)Dot plot depicting number of RPA foci in focus-positive MCF7 cells, as in
Figure 1. Scale bars, 5 m.
cus counts were also increased in S-phase cells (25 ± 10
in translocase-depleted cells versus 19 ± 7 in control cells;
P < 0.05; Figure 2e). No change in RPA staining pattern
was observed in MCF7 cells following translocase deple-
tion; RPA-staining positive cells displayed the relatively dif-
fuse staining pattern characteristic of unperturbed S-phase
rather than the focal staining pattern seen in S33 over-
expressing RAD51. Together, these data indicate RAD54
family translocases prevent accumulation of RPA-negative
RAD51 foci, especially in non-S-phase cells.
As for S33 cells overexpressing RAD51, MCF7 cells
could be induced to form RPA foci by irradiation, even
after translocase depletion (Figure 2). We observed a 1.6-
fold increase in the RPA staining-positive cell fraction with
an average of 39 ± 19 RPA foci/nucleus (Figure 2a,f). Ap-
proximately 68–86% of irradiation-inducedRAD51 foci co-
localized with RPA in both translocase-depleted and con-
trol cells. Thus, the RAD51 foci induced by depletion of
RAD54L+RAD54B are different from those induced by ir-
radiation in that they do not co-localize with RPA. Again,
these results suggest that translocase depletion causes accu-
mulation of RAD51 at sites that do not contain ssDNA.
We observed similar results in Rad54l−/−Rad54b−/−
mouse embryonic stem cells (Supplementary Figure S4).
These cells were previously reported to have higher than
normal levels of RAD51 foci in meiosis, and we found the
same to be true during somatic growth (35). As in the hu-
man tumor cell experiments, only a small fraction of the
RAD51 foci seen in Rad54l−/−Rad54b−/− cells were asso-
ciated with an RPA focus. Upon irradiation, the major-
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ity of RAD51 foci co-localized with RPA. These findings
support the conclusion from siRNA experiments that loss
of RAD54L+RAD54B function leads to elevated levels of
RAD51 foci that are not associated with RPA.
To further support the conclusion that RAD51 foci ob-
served in RAD54L+RAD54B depleted cells are not as-
sociated with DNA damage, we examined localization of
RAD51 and two key DNA damage markers, 53BP1 and
 -H2AX. Both  -H2AX and 53BP1 accumulate at DNA
ends created by DSBs and collapsed replication forks (50–
53). Translocase depletion resulted in a 2-fold increase in
the average number of RAD51 foci/nucleus (4 ± 5 NS ver-
sus 8 ± 7 siRAD54L+RAD54B; P < 0.001; Figure 3a, d).
However, RAD54L+RAD54B depletion did not increase
the number of 53BP1 (4 ± 5 versus 4 ± 6 foci/nucleus) or
H2AX foci (5 ± 3 versus 7 ± 5 foci/nucleus) compared to
controls (Figure 3 a,b,e,f). Furthermore, in RAD54L+B de-
pleted cells, on average only 24 and 23% of RAD51 foci co-
localized with 53BP1 and H2AX, respectively. There is no
significant difference in the number of 53BP1 and H2AX
foci between controls and translocase-depleted cells, so the
co-localizing foci observed are unlikely to be as a result
of increased spontaneous DNA damage. Both H2AX
and 53BP1 foci arise during S phase in unperturbed cells
(54,55). Thus, the RAD51 foci in translocase-depleted cells
that co-localize with DNA damage markers likely repre-
sent stalled/collapsed replication forks. In contrast, irra-
diation resulted in 3- and 5-fold increases in H2AX and
53BP1 foci, respectively, and 83–86% of RAD51 foci exhib-
ited co-localization with 53BP1 and H2AX. This indicates
that the majority of RAD51 foci that accumulate following
translocase depletion in the absence of irradiation mark un-
damaged sites.
RAD51 focus formation at DNA damage sites is re-
stricted to S and G2 phases of the cell cycle (56,57).
Thus, we determined if RAD51 accumulation in
RAD54L+RAD54B depleted cells was occurring in S
phase by staining cells with proliferating cell nuclear
antigen (PCNA), which stains cells specifically undergo-
ing replication (Figure 3c,g; (58). RAD54L+RAD54B
depletion resulted in a significant increase in RAD51 in
PCNA-negative (5 ± 5 versus 2 ± 2 RAD51 foci; P <
0.005) and PCNA-positive cells (13 ± 6 versus 9 ± 4; P <
0.05). This confirms our interpretation of the RPA staining
data, showing definitively that RAD51 accumulation in
translocase-depleted cells is not restricted to S phase.
Similar results were obtained in S33 cells overexpressing
RAD51 (data not shown). Metaphase and anaphase
chromosomes were also decorated with RAD51 fibers,
providing further evidence that these structures are not
restricted to S-phase (as described below).
RAD54L+B depleted MDAMB231 and PC-3 cells accumu-
late nondamage-associated RAD51 foci
We verified the results in MCF7 cells by determining
the effect of RAD54L+RAD54B depletion in two addi-
tional cell lines: the prostate cancer cell line, PC-3 and
the triple-negative breast cancer cell line, MDAMB231
(Supplementary Figure S5). In MDAMB231 cells, translo-
case depletion with either siRAD54L+RAD54B (22 ± 21
RAD51 foci/nucleus) or siRAD54L+RAD54B-2 (25 ± 19
RAD51 foci/nucleus) significantly increased RAD51 fo-
cus counts when compared to controls (7 ± 9 RAD51
foci/nucleus, P < 0.001). As was the case with MCF7
cells, depletion of translocases did not increase 53BP1 focus
counts (8 ± 8 foci, siNS, 6 ± 4 foci siRAD54L+RAD54B-
2, 7 ± 4 siRAD54L+RAD54B 53BP1 foci/nucleus).
RAD54L+RAD54B depletion in PC-3 cells increased the
number for RAD51 foci 2-fold from 6 ± 5 foci/nucleus in
controls to 12 ± 7 foci/nucleus, but did not have an effect
on 53BP1 focus counts (7 ± 5 versus 4 ± 5; P< 0.001; Sup-
plementary Figure S5d–f). These results indicate that the
ability of RAD54 to limit RAD51 focus accumulation can
be seen in multiple tumor lines.
Previously, we demonstrated that PC-3 cells accumu-
lated RAD51 on undamaged DNA when treated with RS-
1, a small molecule that enhances the ability of RAD51
to bind both ss and dsDNA (36,59). Cells were further
sensitized to RS-1 treatment by depletion of the RAD54
translocases (36). This led us to hypothesize that combin-
ing depletion of translocases with RS-1 treatment might
further increase RS-1-induced RAD51 foci. To test this,
we examined RS-1-induced RAD51 accumulation in cells
depleted of RAD54L+RAD54B (Supplementary Figure
S5d–f). Treatment of RAD54L+RAD54B depleted cells in-
creased the average RAD51 focus counts from 26 ± 11 to
41 ± 18 foci/nucleus compared to RS-1 treatment alone
(P < 0.001). Strikingly, 71% of RAD54L+RAD54B nuclei
contained greater than 30 RAD51 foci/nucleus after RS-1
treatment compared to just 38% of nuclei with RS-1 treat-
ment alone (P = 0.002). Thus, RAD54L+RAD54B deple-
tion combined with RS-1 treatment increases RAD51 focus
accumulation.
HumanRAD54 dissociates RAD51 from dsDNA in a purified
system
Studies (60,61) have established that yeast Rad54 has the
fundamental biochemical activity of disassembling yeast
Rad51-dsDNA filaments. However, evidence for the human
RAD54 disassembly of RAD51 filaments in vitro remained
to be demonstrated. To this end, we used the modified elec-
trophoretic mobility shift assay previously employed with
the yeast system (60,61). In this assay (Figure 4a), Rad51 fil-
aments are formed on radiolabeled dsDNA and then excess
unlabeled ‘scavenger’ dsDNA is added to bind any Rad51
that disassembles from the original nucleoprotein filaments
and thus prevent their reassembly on the original dsDNA.
As shown in Figure 4b, yeast Rad51-dsDNAfilaments enter
the gel as a discrete species and are disassembled by Rad54
in a time-dependent manner to produce freely migrating ds-
DNA.Under the samemagnesium-ATP conditions, human
RAD51–dsDNA complexes do not enter the gel and remain
in the well as aggregated species. It is not clear if these rep-
resent individual RAD51 filaments, complex filament net-
works or nonspecific DNA co-aggregates. RAD51-ssDNA
filaments formed under similar conditions are unstable and
are not productive for DNA strand exchange, while the ad-
dition of calcium ions inhibits RAD51 ATP hydrolysis and
allows formation of extended, stable filaments (62). When
calcium is included in the reactions (Figure 4b, c), RAD51-
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Figure 3. Depletion of translocases does not result in an increase in markers of DNA damage. Representative images of nuclei containing RAD51 foci and
either (a) 53BP1 foci (b)  -H2AX foci or (c) PCNA. (d-g) Dot plots representing the number of foci in MCF7 cells after the indicated treatments for d)
RAD51, (e) 53BP1 (f) gH2AX (g) and RAD51 in PCNA-negative and PCNA-positive nuclei. Red lines and numbers above the graphs represent the mean
RAD51 focus counts. Scale bar; 5 m.
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Figure 4. Human RAD54 disassembles human RAD51-dsDNA filaments in vitro. (a) Scheme of electrophoretic mobility shift assay (EMSA) for RAD54-
mediated disassembly of RAD51-dsDNA filaments. A 3 kilobase dsDNA substrate (6 M bp) that is 5′ end-labeled with 32P is incubated with RAD51
(1.5 M) for 20 min at room temperature (∼23◦C). RAD54 (100 nM) is then added, or identical buffer, and incubation continued for 2 min. A 30 M
bp pUC19 ‘scavenger’ dsDNA is then added to bind RAD51 protein that is removed by RAD54, preventing rebinding to the original dsDNA. After
1 or 2 h, the reaction is stopped by fixation with 0.25% glutaraldehyde and subject to TAE-agarose gel electrophoresis. (b) Phosphorimage of EMSA
performed with human or yeast Rad51+/- Rad54 cognate pairs. Reactions contained 4 mMMgCl2 and CaCl2 where indicated. (c) Calcium titration into
the disassembly reaction, with 4 mM magnesium ion and the indicated concentration of calcium. Quantitation corresponding to each lane condition is
provided underneath the gel image. The first lane (marked ‘s’) contains DNA substrate and no protein and represents 100% signal to which the other
lanes’ free DNA are normalized. Error bars are the standard deviation of three independent experiments. (d) Experiment performed with a 705 nt ssDNA
substrate (6Mnucleotide) and 0.5mMCaCl2. The doublet band seen in the substrate only lane, marked ‘s’, is likely due to alternative secondary structural
forms of the ssDNA substrate. Error bars are the standard deviation of three independent experiments.
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dsDNA filaments now enter the gel as a discrete species,
and these filaments show very little turnover as evident by a
lack of increase in the level of free substrate with time. The
addition of RAD54 causes the nucleoprotein complexes to
supershift into the wells. While the disassembly of RAD51-
dsDNA filaments is inefficient at higher calcium concentra-
tions (2 mM), titrating down the calcium concentration al-
lows a progressive increase in the amount of free dsDNA
that is liberated by RAD54 in a time-dependent manner
(Figure 4c). This behavior is analogous to experiments with
yeast proteins, where both the Rad54 and Rad51 ATPase
activities are required for optimal disassembly of Rad51-
dsDNA filaments (61). To test the possibility that RAD54
might also cause filament disassembly on ssDNA, we per-
formed the assay under the low calcium (0.5 mM) condition
and formed RAD51 filaments on a 705 nt ssDNA substrate
(Figure 4d). After 2 h of incubation, all ssDNA remained
bound by RAD51 and there was no significant difference
in the migration of nucleoprotein species with or without
RAD54. Taken together with the observation that ssDNA
without secondary structure does not support ATP hydrol-
ysis by RAD54 (18), these data demonstrate that RAD54
removes RAD51 specifically from dsDNA and not ssDNA.
Translocase depletion does not alter RAD51 protein levels
Taken together, the results described above strongly suggest
that an imbalance of RAD51 and RAD54L+RAD54B lev-
els results in the accumulation of a dsDNA-bound form of
RAD51. Given that more extensive RAD51 structures form
in S33 cells upon RAD51 overexpression than in the other
tumor lines in which RAD51 levels are not artificially el-
evated, the results suggest that induction of RAD51 over-
expression in S33 yields a relatively high level of RAD51
expression. Indeed, analysis of RAD51 expression levels by
western blotting showed that induction of RAD51 overex-
pression in S33 cells increases RAD51 to 4 M while the
level of expression of RAD51 was 9- to 13-fold lower in the
other lines: 0.32 M in MCF7, 0.35 M in PC-3, 0.47 M
in MDAMB231 cells (Supplementary Figure S1a). Impor-
tantly, depletion of RAD54L+RAD54B did not result in an
alteration in RAD51 levels in any of the cell lines, indicat-
ing that observed increases in RAD51 fibers and foci result
from redistribution of the protein in the nucleus.
The level of RAD51 expression observed in tumor lines is suf-
ficient to promote substantial binding of RAD51 to dsDNA
RAD51 was previously shown to bind dsDNA directly
by electrophoretic mobility shift assay (63). Similar results
were obtained in a study of yeast Rad51 using a solution
assay (1). We confirmed and extended this observation for
human RAD51 using a solution DNA binding assay (59).
Wemeasured binding ofRAD51 to a 162 bp dsDNAduplex
substrate with hairpin DNA ends to prevent strand disso-
ciation. We found that 0.32 M RAD51 was sufficient to
detect 64% of the maximal dsDNA binding (Supplemen-
tary Figure S6). Thus, the concentration of RAD51 in the
human tumor cells examined here exceeds that required for
direct binding to dsDNA in vitro.
Induction of nondamage-associated RAD51 foci is associated
with reduced cell growth
Next, we studied the impact of RAD51 overexpression and
RAD54L+RAD54B depletion on cellular growth. RAD51
overexpression in S33 cells has previously been shown to
decrease plating efficiency (6). To extend this observation,
we monitored the ability of cells to perform DNA synthe-
sis (i.e. to incorporate EdU) following changes in RAD51
and/or translocase levels. Cells pulsed with EdU for 45 min
were subsequently quantified for EdU staining (Figure 5a).
Both RAD51 overexpression and translocase depletion de-
creased the fraction of EdU-positive S33 cells about 1.5-
fold (30 ± 4% and 28 ± 4%, respectively) relative to con-
trol cells (44 ± 4%). Furthermore, the combination of the
two treatments resulted in a synergistic block to prolifera-
tion; the EdU-positive fraction was reduced 4.5-fold (10 ±
2%; P < 0.0005) compared to the control. In MCF7 cells,
translocase depletion similarly resulted in a significant re-
duction in the EdU positivity (Figure 5a), with a striking
4.7-fold reduction at 72 h (10 ± 7% of translocase-depleted
cells versus 47 ± 9% of control cells; P < 0.05). These re-
sults suggest that the accumulation of RAD51 complexes
on undamaged chromosomes blocks growth.
Replication defects associated with accumulation of
nondamage-associated RAD51 complexes
The finding that reduction of translocase activity is asso-
ciated with reduced proliferation raised the possibility that
replication is blocked. To test this possibility, we employed
a nascent DNA fiber technique to compare the efficiency
of replication with reduced translocase levels to controls.
Cells were pulsed labeled with IdU (red) for 20 min fol-
lowed by a second 20-min pulse with CldU (green). DNA
fiber spreads were prepared and fork progression examined
by immunostaining. Themajority of DNAfibers comprised
adjacent IdU and CldU signals indicating continuous repli-
cation fork elongation during both pulses (Figure 5b). To
determine if accumulation of RAD51 complexes is associ-
ated with an increase in fork stalling, we determined the
percentage of forks containing IdU only (red) (64). In S33
cells, RAD51 overexpression resulted in a 2-fold increase in
stalled replication forks compared to controls (11± 2% ver-
sus 5 ± 2%; P < 0.05). Depletion of RAD54L+RAD54B
in cells overexpressing RAD51 further increased the per-
centage of stalled replication forks (19 ± 2%; P < 0.001).
In MCF7 cells, RAD54L+RAD54B depletion resulted in
a similar increase in stalled replication forks compared to
controls (23 ± 2% versus 8 ± 2%). Together, these results
indicate that accumulation of RAD51 foci and fibers is as-
sociated with replication blockage.
Next, we measured fork progression by measuring the
CldU/IdU tract length ratio. A decrease in replication
fork progression results in shorter CldU tracts com-
pared to IdU (lower CldU/IdU ratio; Figure 5c; (38,65).
RAD54L+RAD54B depletion had no effect on replication
progression in cells with lower levels of RAD51 (CldU/IdU
ratio: 0.8 in siRAD54L+B versus 0.76 in NS, respec-
tively). Induction ofRAD51 overexpression significantly re-
duced replication fork progression (CldU/IdU; 0.67; P <
0.01). Replication fork progression was further decreased
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Figure 5. Proliferation and replication defects in S33 and MCF7 cells after RAD54 translocase depletion. (a) EdU assay for cell proliferation. Graph
represents the percentage of cells that incorporated EdU in S33 cells (48 h) andMCF7 (48 and 72 h) after the indicated treatments. Note that reductions in
the percent of EdU-positive cells can result from blocks at any phase of the cell cycle. (b) Quantification of stalled replication forks in S33 cells and MCF7
cells using the DNA fiber spreading technique. Images above graph represent a replication tract that has incorporated both IdU (red) and CldU (green)
during consecutive pulses and a tract that incorportated IdU only (stalled fork). (c) Replication fork progression in (c) S33 cells and (d) MCF7 cells. The
ratio of CldU/IdU tracts are plotted. Error bars, SE.
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by depletion of RAD54L+RAD54B (CldU/IdU: 0.6, P
< 0.001). In MCF7 cells, RAD54L+RAD54B depletion
also significantly decreased replication fork progression
(CldU/IdU ratio: 0.47) compared to controls (CldU/IdU:
0.68, P < 0.001; Figure 5d). Together, these data suggest
that accumulation of DNA bound RAD51 impairs replica-
tion fork progression by decreasing replication fork speed
and/or increasing the frequency of replisome stalling.
Mitotic defects associated with accumulation of nondamage-
associated RAD51 complexes
In Saccharomyces cerevisiae, Rad51 accumulation on mi-
totic chromosomes has been shown to cause chromosome
loss (31). To determine whether nondamage-associated
RAD51 complexes similarly cause chromosome instabil-
ity in human cells, we examined nuclear morphology in
S33 and MCF7 cells. In S33 cells with lower RAD51, ap-
proximately 10 ± 4% of nuclei contained at least one mi-
cronucleus, but other abnormalities were not seen. By con-
trast, when RAD51 was overexpressed 80–86% of control
and translocase-depleted cells displayed dramatic defects
in nuclear morphology; filament-containing nuclei were
multinucleate, contained micronuclei or were connected by
DNA bridges (Figure 6a). We then examined the effects
of RAD54L+RAD54B depletion in MCF7 cells. MCF7
cells depleted of RAD54L+RAD54B displayed a higher
frequency of micronuclei (20 ± 2%) compared to controls
(5 ± 1%), indicating that this cell line requires normal ex-
pression of RAD54L+RAD54B for genome stability (Fig-
ure 6a).
Multinucleate cells can arise as a result of severe de-
fects in chromosomes condensation and segregation (66–
68). Therefore, we sought evidence for defects during
metaphase and anaphase in S33 and MCF7 cells contain-
ing nondamage-associatedRAD51 complexes by immunos-
taining cells for the mitotic spindle component, -tubulin.
Chromosomes appeared undercondensed in 27 ± 6% of
metaphase nuclei in S33 cells following RAD51 overexpres-
sion, compared to 0% of metaphase nuclei expressing lower
RAD51 levels (Figure 6b,d). Combining RAD51 overex-
pression with translocase depletion further increased the
percentage of mitotic figures with condensation defects 2-
fold (52 ± 7%; P < 0.05). We verified this result by deplet-
ing cells with siRAD54L+RAD54B-2 siRNAs and found
that translocase depletion increased the percentage of mi-
totic figures with condensation defects 2.3-fold (75 ± 33%
siRAD54L+RAD54B-2; 33± 10% siNS; P< 0.05; Supple-
mentary Figure S7a). Strikingly, RAD51 fibers were visible
on 100% (N= 43) of metaphases with condensation defects.
Translocase depletion did not result in detectable condensa-
tion defects in S33 cells that had not been induced to overex-
pressRAD51, norwas this the case inMCF7 cells. Together,
these data indicate that extensive accumulation of RAD51
fibers onmitotic chromosomes blocks normal chromosome
condensation during mitosis.
We then examined chromosome segregation during
anaphase (Figure 6c). Mitotic cells that failed to sepa-
rate into two distinct daughter nuclei were scored as con-
taining segregation defects. They were further separated
into two distinct classes: cells containing a single lagging
chromosome or anaphase bridge (Class I), and those with
multiple lagging chromosomes (Class II, Figure 6e). Over-
expression of RAD51 resulted in an increase in the fre-
quency of mitotic defects from 23 ± 6 to 59 ± 7 (P <
0.05). Translocase depletion combined with RAD51 over-
expression resulted in a dramatic 4-fold increase in the
frequency of Class II defects from 14 ± 9% to 55 ±
15% of anaphases (Figure 6e). A second set of siRNAs
against RAD54L+RAD54B also promoted a similar in-
crease in the frequency of Class II defects (Supplementary
Figure S7b). These data indicate that RAD54L+RAD54B
promote chromosome segregation in cells overexpressing
RAD51. Increases in segregation defects were also observed
without artificial overexpression of RAD51. In translocase
depleted MCF7, 27 ± 6% of cells exhibited Class I seg-
regation defects compared to 3.5 ± 2.4% of control cells
(P < 0.005; Figure 6c,e). In MDAMB231 cells, 38 ± 10%
of cells depleted for RAD54L+RAD54B exhibited Class I
segregation defects compared to 17 ± 8% of controls and
4 ± 4% of nuclei exhibited Class II defects (Supplemen-
tary Figure S7c). Thus, conditions that promote accumu-
lation of nondamage-associated RAD51 complexes, either
by RAD51 overexpression and/or RAD54L+RAD54B de-
pletion, generate genome instability via segregation errors.
DISCUSSION
Here, we provide evidence that human RAD54 family
translocases function to limit accumulation of DNA-bound
RAD51 complexes in the absence of inducedDNAdamage.
The data support a model in which RAD51 binds undam-
aged sites of dsDNA, rather than being recruited to sites of
damaged DNA containing ssDNA tracts. This interpreta-
tion is consistent with the known dsDNA binding activity
of RAD51 (1,69) and the concentration of RAD51 in the
cell (as discussed further below). The interpretation is also
supported by our demonstration of hRAD54’s ability to
dissociate RAD51 fromdsDNA,which is in agreement with
previouswork on the orthologous yeast protein (60,61). The
data presented argue that the RAD54 family translocases
have an evolutionarily conserved function that prevents the
accumulation of potentially toxic RAD51–dsDNA com-
plexes (31,32). We propose that this function of RAD54
family translocases is important for genome stability be-
cause accumulation of RAD51 complexes on dsDNA is as-
sociated with inhibition of replication fork progression and
interruption of proper chromosome segregation.
RAD51 fibers may be helical nucleoprotein filaments
Previous work in S33 cells showed that RAD51 fibers form
as a consequence of RAD51 overexpression. It was not
clear, however, if these fibers were a DNA-bound form of
the protein or not. We present three lines of evidence con-
sistent with the notion that the fibers are bound to DNA: (i)
they are sensitive to DNAse treatment, (ii) they co-localize
with DNA-staining threads that are seen connecting nuclei
following translocase depletion and (iii) their length and
abundance increases when dsDNA-specific DNA translo-
cases are depleted. We speculate that RAD51 fibers are the
helical RAD51 nucleoprotein filaments observed in purified
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Figure 6. Mitotic defects in S33 and MCF7 cells after RAD54 translocase depletion. (a) Representative images of S33 cells and/or MCF7 cells. Three
independent images of each type of abnormality are shown. Graphs depict quantification of nuclear aberrations. (b) Representative images of metaphases
in S33 andMCF7 cells after indicated treatments. Cells were stained for RAD51 (green) and -Tubulin (red). (c)Representative images of anaphases in S33
and MCF7 cells after indicated treatments. (d) Quantification of mitotic figures displaying chromosome condensation defects. (e) Percentage of mitoses
with Class I or Class II segregation defects. Error bars, SE. NS, nonilencing. Scale bar, 10 m.
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systems. Given that helical dsDNA-RAD51 nucleoprotein
filaments contain 2.5 kb per micron, the assumption that
fibers correspond to helical filaments implies that they in-
volve tracts of DNA that are on the order of 5 kb in length.
RAD51 and other members of the RecA family are well
known to form such long filaments; indeed, such filaments
have been extensively characterized biochemically (69–71).
Although we favor the hypothesis that RAD51 fibers ob-
served in vivo are composed of helical filaments, further
studies are required to determine their molecular structure.
RAD51 cellular concentration is sufficient to promote direct
binding to dsDNA
We estimated the cellular concentration of RAD51 in hu-
man tumor cells and found that the concentration inMCF7
is about 0.32M, a concentration at which purifiedRAD51
displays significant binding to dsDNA. Given the complex-
ity of chromatin, it is difficult to estimate the concentration
of nuclear dsDNA segments available to bind RAD51 di-
rectly. However, the concentration of genomic DNA in a
mammalian nucleus can be estimated to be about 10mMbp
(based on a diploid genome size of 6.5 Gbp and an average
nuclear volume of 1.0 x 10−6 l). Thus, the concentration
of RAD51 in the nucleus is sufficient to promote direct ds-
DNAbinding even if less than 1/10,000 of the dsDNA is ac-
cessible. We view these data as supporting the proposal that
the RAD51 foci observed in translocase depletion experi-
ments arise as a consequence of direct binding of RAD51
to dsDNA.
The effects of RAD51-RAD54 imbalance
We examined the effects of translocase depletion in three
different contexts that we believe differ in the degree
of imbalance between RAD51 dsDNA association and
tranlocase-mediated dissociation. In S33 cells with low lev-
els of RAD51, RAD54L+RAD54B depletion leads to ami-
nor imbalance resulting in a slight, but significant accumu-
lation of RAD51 foci specifically in S-phase cells. In S33
cells, artificial induction of very high levels of RAD51 pro-
tein leads to a much greater imbalance resulting in the accu-
mulation of long RAD51 fibers (6). These abnormal struc-
tures become longer and somewhat more numerous when
translocase activity is depleted. In human tumor cells such
as MCF7, RAD51 forms higher levels of spontaneous foci
that most often appear as simple resolution-limited stain-
ing foci (14). If such foci represent canonical RAD51 heli-
cal filaments, their contour lengths must be less than 400
bp, given the resolution of the imaging method. Experi-
mental reduction of translocase expression in MCF7, PC-3
and MDAMB231 cells results in a moderate imbalance be-
tween RAD51 and RAD54 activity, increasing the number
of RAD51 foci and resulting in the accumulation of a small
number of fibers.
Differing severity of chromosomal abnormalities caused
by RAD51 overexpression or RAD54L+RAD54B deple-
tion is consistent with being caused by differing degrees
of imbalance of RAD51 and RAD54L+RAD54B activity.
Depletion of translocases in MCF7 cells, which results in
a modest accumulation of RAD51 structures, is associated
with relatively modest anaphase abnormalities that typi-
cally appear to involve a single lagging chromosome (72).
Induction of very high levels of chromosome-associated
RAD51 complexes is associated with more severe chromo-
some abnormalities. Indeed, severe defects in chromosome
condensation and segregation has been shown previously
to lead to severe abnormalities in nuclear morphology (66–
68,73). In the case of cells induced to express artificially high
levels of RAD51, no additional increase in the severity of
associated defects was detected by translocase depletion, a
result we interpret to suggest that artificial overexpression
of RAD51 in S33 cells results in the maximum defect ob-
servable in our phenotypic assays.
In contrast to the correspondence of the severity of segre-
gation defects to the level of RAD51-RAD54 imbalance in
overexpressing S33 cells andMCF7 cells, the replication as-
say we employed showed similar defects caused by translo-
case depletion in the two types of cells. However, this re-
sult is likely to be misleading due to the fact that the DNA
combing assay is only capable of detecting defects at sites
still engaged in replication at the time of DNA labeling; if
most forks are blocked at the time of labeling in S33, the
assay would not necessarily have detected a relatively se-
vere replication defect in overexpressing S33 cells. Support-
ing this interpretation is the observation that high levels
of RAD51 expression in S33 cells result in the redistribu-
tion of RPA from the relatively diffuse pattern associated
with normal S phase to the punctate pattern that is char-
acteristic of a severe replication blockage (48,49). No such
RPA redistribution was observed in translocase-depleted
MCF7 cells, suggesting that the replication blockage is not
as severe in that situation. Alternatively or in addition to
direct effects on replication fork stalling, accumulation of
RAD51 on undamaged DNA may result in a significant
reduction in the free pool of RAD51 available for repair
of stalled/collapsed replication forks. Previous studies have
indicated RAD51 protects replication forks and mediates
replication fork restart in response to hydroxyurea (64,74).
Thus, the replication defects observed in cells containing
nondamage-associated RAD51 complexes may arise due to
sequestration of RAD51, and/or RAD51-associated repair
factors, away from stalled replication forks.
The nature of RAD51-mediated segregation defects
At least some of the segregation defects observed in cells
containing nondamage-associated RAD51 complexes may
arise due to cells entering mitosis with incompletely repli-
cated DNA. Previous studies have demonstrated that re-
duction of replication fork speed results in segregation er-
rors (75,76). Alternatively or in addition, the presence of
RAD51 complexes bound to DNA during metaphase and
anaphase may block topoisomerase II activity resulting in
accumulation of catenated DNA. Indeed, the phenotypes
observed in S33 andMCF7 cells are reminiscent of topoiso-
merase II depleted cells, which also display mitotic conden-
sation defects, increased micronucleus formation, increased
multinucleated cells, chromosome segregation defects and
PICH-positive DNA bridges (73).
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Implications for cancer
RAD51 overexpression has been observed in a wide vari-
ety of cancer types (8–14,77) and spontaneous RAD51 foci
have been reported in various cancer cell lines (14). Our data
support amodel in which inhibition ofRAD54L+RAD54B
destabilizes the genome under conditions that promote
the accumulation of toxic DNA-bound RAD51 complexes.
These findings indicate that imbalance of RAD51-dsDNA
binding and translocase-mediated RAD51 dissociation is
genome destabilizing. Thus, in addition to its genome sta-
bilizing DNA repair activity, RAD51 may also promote tu-
mor progression in tumors where RAD54 activity is lim-
iting. Because RAD51 overexpression and spontaneous
RAD51 foci are common features of malignant cells, our
findings suggest a possible role for nondamage-associated
RAD51 complexes in malignant progression. A second on-
cologic implication is that the balance of RAD51-RAD54
activities may represent a drug target for cancer treatment
because tumor cells expressing high levels of RAD51 may
prove to be differentially sensitive to compounds such as
streptonigrin that inhibit RAD54 (78). Proof in principle
for this targeting strategy is provided by RS-1, which en-
hances toxic RAD51 activity (36).
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ACKNOWLEDGEMENT
We thank Jenny Flygare for the S33 HT1080 cell line,
Roland Kanaar for Rad54l-/- Rad54b-/- ES cells, Akira
Shinohara for RAD51 antibodies and Patrick Sung for the
RAD54B antibodies.
FUNDING
National Institutes of Health [CA142642-02 to P.P.C.,
5T32CA009594 to J.M.M., GM58015 to W.D.H.,
GM50936 to D.K.B.]. Funding for open access charge:
National Institutes of Health [GM50936 to D.K.B].
Conflict of interest statement.None declared.
REFERENCES
1. Zaitseva,E.M., Zaitsev,E.N. and Kowalczykowski,S.C. (1999) The
DNA binding properties of Saccharomyces cerevisiae Rad51 protein.
J. Biol. Chem., 274, 2907–2915.
2. Tsuzuki,T., Fujii,Y., Sakumi,K., Tominaga,Y., Nakao,K.,
Sekiguchi,M., Matsushiro,A., Yoshimura,Y. and Morita,T. (1996)
Targeted disruption of the Rad51 gene leads to lethality in embryonic
mice. Proc. Natl. Acad. Sci. U.S.A., 93, 6236–6240.
3. Sonoda,E., Sasaki,M.S., Buerstedde,J.M., Bezzubova,O.,
Shinohara,A., Ogawa,H., Takata,M., Yamaguchi-Iwai,Y. and
Takeda,S. (1998) Rad51-deficient vertebrate cells accumulate
chromosomal breaks prior to cell death. EMBO J., 17, 598–608.
4. San Filippo,J., Sung,P. and Klein,H. (2008) Mechanism of eukaryotic
homologous recombination. Annu. Rev. Biochem., 77, 229–257.
5. Eggler,A.L., Inman,R.B. and Cox,M.M. (2002) The
Rad51-dependent pairing of long DNA substrates is stabilized by
replication protein A. J. Biol. Chem., 277, 39280–39288.
6. Flygare,J., Falt,S., Ottervald,J., Castro,J., Dackland,A.L., Hellgren,D.
and Wennborg,A. (2001) Effects of HsRad51 overexpression on cell
proliferation, cell cycle progression, and apoptosis. Expl. Cell Res.,
268, 61–69.
7. Richardson,C., Stark,J.M., Ommundsen,M. and Jasin,M. (2004)
Rad51 overexpression promotes alternative double-strand break
repair pathways and genome instability. Oncogene, 23, 546–553.
8. Hine,C.M., Seluanov,A. and Gorbunova,V. (2008) Use of the Rad51
promoter for targeted anti-cancer therapy. Proc. Natl. Acad. Sci.
U.S.A., 105, 20810–20815.
9. Maacke,H., Jost,K., Opitz,S., Miska,S. and Yuan,Y. (2000) DNA
repair and recombination factor Rad51 is over-expressed in human
pancreatic adenocarcinoma. Oncogene. 19, 291–2795.
10. Maacke,H., Opitz,S., Jost,K., Hamdorf,W., Henning,W., Kru¨ger,S.,
Feller,A.C., Lopens,A., Diedrich,K., Schwinger,E. et al. (2000)
Over-expression of wild-type Rad51 correlates with histological
grading of invasive ductal breast cancer. Int. J. Cancer, 88, 907–913.
11. Connell,P.P., Jayathilaka,K., Haraf,D.J., Weichselbaum,R.R.,
Vokes,E.E. and Lingen,M.W. (2006) Pilot study examining tumor
expression of RAD51 and clinical outcomes in human head cancers.
Int. J. Oncol., 28, 1113–1119.
12. Qiao,G.-B., Wu,Y.-L., Yang,X.-N., Zhong,W.-Z., Xie,D., Guan,X.-Y.,
Fischer,D., Kolberg,H.-C., Kruger,S. and Stuerzbecher,H.-W. (2005)
High-level expression of Rad51 is an independent prognostic marker
of survival in non-small-cell lung cancer patients. Br. J. Cancer, 93,
137–143.
13. Takenaka,T., Yoshino,I., Kouso,H., Ohba,T., Yohena,T.,
Osoegawa,A., Shoji,F. and Maehara,Y. (2007) Combined evaluation
of Rad51 and ERCC1 expressions for sensitivity to platinum agents in
non-small cell lung cancer. Int. J. Cancer, 121, 895–900.
14. Raderschall,E., Stout,K., Freier,S., Suckow,V., Schweiger,S. and
Haaf,T. (2002) Elevated Levels of Rad51 Recombination Protein in
Tumor Cells. Cancer Res., 62, 219–225.
15. Heyer,W.-D., Li,X., Rolfsmeier,M. and Zhang,X.-P. (2006) Rad54:
the Swiss Army knife of homologous recombination? Nucleic Acids
Res., 34, 4115–4125.
16. Nimonkar,A.V., Amitani,I., Baskin,R.J. and Kowalczykowski,S.C.
(2007) Single molecule imaging of Tid1/Rdh54, a Rad54 homolog
that translocates on duplex DNA and can disrupt joint molecules. J.
Biol. Chem., 282, 30776–30784.
17. Amitani,I., Baskin,R.J. and Kowalczykowski,S.C. (2006)
Visualization of Rad54, a chromatin remodeling protein,
translocating on single DNA molecules.Mol. Cell, 23, 143–148.
18. Swagemakers,S.M., Essers,J., de Wit,J., Hoeijmakers,J.H. and
Kanaar,R. (1998) The human RAD54 recombinational DNA repair
protein is a double-stranded DNA-dependent ATPase. J. Biol. Chem.,
273, 28292–28297.
19. Petukhova,G., Sung,P. and Klein,H. (2000) Promotion of
Rad51-dependent D-loop formation by yeast recombination factor
Rdh54/Tid1. Genes Dev., 14, 2206–2215.
20. Tanaka,K., Kagawa,W., Kinebuchi,T., Kurumizaka,H. and
Miyagawa,K. (2002) Human Rad54B is a double-stranded
DNA-dependent ATPase and has biochemical properties different
from its structural homolog in yeast, Tid1/Rdh54. Nucleic Acids Res.,
30, 1346–1353.
21. Li,X. and Heyer,W.D. (2009) RAD54 controls access to the invading
3′-OH end after RAD51-mediated DNA strand invasion in
homologous recombination in Saccharomyces cerevisiae. Nucleic
Acids Res., 37, 638–646.
22. Wright,W.D. and Heyer,W.-D. (2014) Rad54 functions as a
heteroduplex DNA pump modulated by its DNA substrates and
Rad51 during D loop formation.Mol. Cell, 53, 420–432.
23. Hicks,W.M., Yamaguchi,M. and Haber,J.E. (2011) Real-time analysis
of double-strand DNA break repair by homologous recombination.
Proc. Natl. Acad. Sci. U.S.A., 108, 3108–3115.
24. Sinha,M. and Peterson,C.L. (2008) A Rad51 presynaptic filament is
sufficient to capture nucleosomal homology during recombinational
repair of a DNA double-strand break.Mol. Cell, 30, 803–810.
25. Kwon,Y., Seong,C., Chi,P., Greene,E.C., Klein,H. and Sung,P. (2008)
ATP-dependent chromatin remodeling by the Saccharomyces
cerevisiae homologous recombination factor Rdh54. J. Biol. Chem.,
283, 10445–10452.
26. Zhang,Z., Fan,H.-Y., Goldman,J.A. and Kingston,R.E. (2007)
Homology-driven chromatin remodeling by human RAD54. Nat.
Struct. Mol. Biol., 14, 397–405.
27. Sugawara,N., Ivanov,E.L., Fishman-Lobell,J., Ray,B.L., Wu,X. and
Haber,J.E. (1995) DNA structure-dependent requirements for yeast
RAD genes in gene conversion. Nature, 373, 84–86.
Nucleic Acids Research, 2015, Vol. 43, No. 6 3195
28. Alexeev,A., Mazin,A. and Kowalczykowski,S.C. (2003) Rad54
protein possesses chromatin-remodeling activity stimulated by the
Rad51-ssDNA nucleoprotein filament. Nat. Struct. Biol., 10,
182–186.
29. Mazin,A.V. (2003) A novel function of Rad54 protein. Stabilization of
the Rad51 nucleoprotein filament. J. Biol. Chem., 278, 14029–14036.
30. Wolner,B., van Komen,S., Sung,P. and Peterson,C.L. (2003)
Recruitment of the recombinational repair machinery to a DNA
double-strand break in yeast.Mol. Cell, 12, 221–232.
31. Shah,P.P., Zheng,X., Epshtein,A., Carey,J.N., Bishop,D.K. and
Klein,H.L. (2010) Swi2/Snf2-related translocases prevent
accumulation of toxic Rad51 complexes during mitotic growth.Mol.
Cell, 39, 862–872.
32. Holzen,T.M., Shah,P.P., Olivares,H.A. and Bishop,D.K. (2006)
Tid1/Rdh54 promotes dissociation of Dmc1 from
nonrecombinogenic sites on meiotic chromatin. Genes Dev., 20,
2593–2604.
33. Symington,L.S. and Heyer,W.D. (2006) Some disassembly required:
role of DNA translocases in the disruption of recombination
intermediates and dead-end complexes. Genes Dev., 20, 2479–2486.
34. Agarwal,S., van Cappellen,W.A., Gue´nole´,A., Eppink,B.,
Linsen,S.E.V., Meijering,E., Houtsmuller,A., Kanaar,R. and Essers,J.
(2011) ATP-dependent and independent functions of Rad54 in
genome maintenance. J. Cell Biol., 192, 735–750.
35. Wesoly,J., Agarwal,S., Sigurdsson,S., Bussen,W., Van Komen,S.,
Qin,J., van Steeg,H., van Benthem,J., Wassenaar,E., Baarends,W.M.
et al. (2006) Differential contributions of mammalian Rad54 paralogs
to recombination, DNA damage repair, and meiosis.Mol. Cell Biol.,
26, 976–989.
36. Mason,J.M., Logan,H.L., Budke,B., Wu,M., Pawlowski,M.,
Weichselbaum,R.R., Kozikowski,A.P., Bishop,D.K. and Connell,P.P.
(2014) The RAD51-stimulatory compound RS-1 can exploit the
RAD51 overexpression that exists in cancer cells and tumors. Cancer
Res., 74, 3546–3555.
37. Burgess,A., Vigneron,S., Brioudes,E., Labbe´,J.-C., Lorca,T. and
Castro,A. (2010) Loss of human Greatwall results in G2 arrest and
multiple mitotic defects due to deregulation of the cyclin
B-Cdc2/PP2A balance. Proc. Natl. Acad. Sci. U.S.A., 107,
12564–12569.
38. Schwab,R.A., Nieminuszczy,J., Shin-ya,K. and Niedzwiedz,W. (2013)
FANCJ couples replication past natural fork barriers with
maintenance of chromatin structure. J. Cell Biol., 201, 33–48.
39. Maser,R.S., Monsen,K.J., Nelms,B.E. and Petrini,J.H. (1997)
hMre11 and hRad50 nuclear foci are induced during the normal
cellular response to DNA double-strand breaks.Mol. Cell. Biol., 17,
6087–6096.
40. Miura,M., Sasaki,T. and Takasaki,Y. (1996) Characterization of
X-ray-induced immunostaining of proliferating cell nuclear antigen in
human diploid fibroblasts. Radiat. Res., 145, 75–80.
41. Luciani,J.J., Depetris,D., Usson,Y., Metzler-Guillemain,C.,
Mignon-Ravix,C., Mitchell,M.J., Megarbane,A., Sarda,P., Sirma,H.,
Moncla,A. et al. (2006) PML nuclear bodies are highly organised
DNA-protein structures with a function in heterochromatin
remodelling at the G2 phase. J. Cell Scie, 119, 2518–2531.
42. Spence,J.M., Phua,H.H., Mills,W., Carpenter,A.J., Porter,A.C.G. and
Farr,C.J. (2007) Depletion of topoisomerase IIalpha leads to
shortening of the metaphase interkinetochore distance and abnormal
persistence of PICH-coated anaphase threads. J. Cell Scie., 120,
3952–3964.
43. Murti,K.G., He,D.C., Brinkley,B.R., Scott,R. and Lee,S.H. (1996)
Dynamics of human replication protein A subunit distribution and
partitioning in the cell cycle. Exp. Cell Res., 223, 279–289.
44. Dimitrova,D.S., Todorov,I.T., Melendy,T. and Gilbert,D.M. (1999)
Mcm2, but not RPA, is a component of the mammalian early
G1-phase prereplication complex. J. Cell Biol., 146, 709–722.
45. Dimitrova,D.S. and Gilbert,D.M. (2000) Stability and nuclear
distribution of mammalian replication protein A heterotrimeric
complex. Exp. Cell Res., 254, 321–327.
46. Golub,E.I., Gupta,R.C., Haaf,T., Wold,M.S. and Radding,C.M.
(1998) Interaction of human rad51 recombination protein with
single-stranded DNA binding protein, RPA. Nucleic Acids Res., 26,
5388–5393.
47. Raderschall,E., Golub,E.I. and Haaf,T. (1999) Nuclear foci of
mammalian recombination proteins are located at single-stranded
DNA regions formed after DNA damage. Proc. Natl. Acad. Sci.
U.S.A, 96, 1921–1926.
48. Robison,J.G., Elliott,J., Dixon,K. and Oakley,G.G. (2004)
Replication protein A and the Mre11.Rad50.Nbs1 complex
co-localize and interact at sites of stalled replication forks. J. Biol.
Chem., 279, 34802–34810.
49. Sakamoto,S., Nishikawa,K., Heo,S.J., Goto,M., Furuichi,Y. and
Shimamoto,A. (2001) Werner helicase relocates into nuclear foci in
response to DNA damaging agents and co-localizes with RPA and
Rad51. Genes Cells, 6, 421–430.
50. Rogakou,E.P., Pilch,D.R., Orr,A.H., Ivanova,V.S. and Bonner,W.M.
(1998) DNA double-stranded breaks induce histone H2AX
phosphorylation on serine 139. J. Biol. Chem., 273, 5858–5868.
51. Paull,T.T., Rogakou,E.P., Yamazaki,V., Kirchgessner,C.U.,
Gellert,M. and Bonner,W.M. (2000) A critical role for histone H2AX
in recruitment of repair factors to nuclear foci after DNA damage.
Curr. Biol., 10, 886–895.
52. Schultz,L.B., Chehab,N.H., Malikzay,A. and Halazonetis,T.D. (2000)
p53 binding protein 1 (53BP1) is an early participant in the cellular
response to DNA double-strand breaks. J. Cell Biol., 151, 1381–1390.
53. Sengupta,S., Robles,A.I., Linke,S.P., Sinogeeva,N.I., Zhang,R.,
Pedeux,R., Ward,I.M., Celeste,A., Nussenzweig,A., Chen,J. et al.
(2004) Functional interaction between BLM helicase and 53BP1 in a
Chk1-mediated pathway during S-phase arrest. J. Cell Biol., 166,
801–813.
54. MacPhail,S.H., Bana´th,J.P., Yu,Y., Chu,E. and Olive,P.L. (2003) Cell
cycle-dependent expression of phosphorylated histone H2AX:
reduced expression in unirradiated but not X-irradiated G1-phase
cells. Radiat. Res., 159, 759–767.
55. Harding,S.M. and Bristow,R.G. (2012) Discordance between
phosphorylation and recruitment of 53BP1 in response to DNA
double-strand breaks. Cell Cycle, 11, 1432–1444.
56. Tashiro,S., Walter,J., Shinohara,A., Kamada,N. and Cremer,T.
(2000) Rad51 accumulation at sites of DNA damage and in
postreplicative chromatin. J. Cell Biol., 150, 283–291.
57. Tashiro,S., Kotomura,N., Shinohara,A., Tanaka,K., Ueda,K. and
Kamada,N. (1996) S phase specific formation of the human Rad51
protein nuclear foci in lymphocytes. Oncogene, 12, 2165–2170.
58. Moldovan,G.L., Dejsuphong,D., Petalcorin,M.I., Hofmann,K.,
Takeda,S., Boulton,S.J. and D’Andrea,A.D. (2012) Inhibition of
homologous recombination by the PCNA-interacting protein PARI.
Mol. Cell, 45, 75–86.
59. Jayathilaka,K., Sheridan,S.D., Bold,T.D., Bochenska,K.,
Logan,H.L., Weichselbaum,R.R., Bishop,D.K. and Connell,P.P.
(2008) A chemical compound that stimulates the human homologous
recombination protein RAD51. Proc. Natl. Acad. Sci. U.S.A., 105,
15848–15853.
60. Solinger,J.A., Kiianitsa,K. and Heyer,W.D. (2002) Rad54, a
Swi2/Snf2-like recombinational repair protein, disassembles
Rad51:dsDNA filaments.Mol. Cell, 10, 1175–1188.
61. Li,X., Zhang,X.P., Solinger,J.A., Kiianitsa,K., Yu,X., Egelman,E.H.
and Heyer,W.D. (2007) Rad51 and Rad54 ATPase activities are both
required to modulate Rad51-dsDNA filament dynamics. Nucleic
Acids Res., 35, 4124–4140.
62. Ristic,D., Modesti,M., van der Heijden,T., van Noort,J., Dekker,C.,
Kanaar,R. andWyman,C. (2005) Human Rad51 filaments on double-
and single-stranded DNA: correlating regular and irregular forms
with recombination function. Nucleic Acids Res., 33, 3292–3302.
63. Liu,Y., Stasiak,A.Z., Masson,J.-Y., McIlwraith,M.J., Stasiak,A. and
West,S.C. (2004) Conformational changes modulate the activity of
human RAD51 protein. J. Mol. Biol., 337, 817–827.
64. Petermann,E., Orta,M.L., Issaeva,N., Schultz,N. and Helleday,T.
(2010) Hydroxyurea-stalled replication forks become progressively
inactivated and require two different RAD51-mediated pathways for
restart and repair.Mol. Cell, 37, 492–502.
65. Shimura,T., Toyoshima,M., Adiga,S.K., Kunoh,T., Nagai,H.,
Shimizu,N., Inoue,M. and Niwa,O. (2006) Suppression of replication
fork progression in low-dose-specific p53-dependent S-phase DNA
damage checkpoint. Oncogene, 25, 5921–5932.
66. Draviam,V.M., Stegmeier,F., Nalepa,G., Sowa,M.E., Chen,J.,
Liang,A., Hannon,G.J., Sorger,P.K., Harper,J.W. and Elledge,S.J.
(2007) A functional genomic screen identifies a role for TAO1 kinase
in spindle-checkpoint signalling. Nat. Cell Biol., 9, 556–564.
3196 Nucleic Acids Research, 2015, Vol. 43, No. 6
67. Stegmeier,F., Rape,M., Draviam,V.M., Nalepa,G., Sowa,M.E.,
Ang,X.L., McDonald,E.R., Li,M.Z., Hannon,G.J., Sorger,P.K. et al.
(2007) Anaphase initiation is regulated by antagonistic ubiquitination
and deubiquitination activities. Nature, 446, 876–881.
68. Ohsugi,M., Adachi,K., Horai,R., Kakuta,S., Sudo,K., Kotaki,H.,
Tokai-Nishizumi,N., Sagara,H., Iwakura,Y. and Yamamoto,T. (2008)
Kid-mediated chromosome compaction ensures proper nuclear
envelope formation. Cell, 132, 771–782.
69. Ogawa,T., Yu,X., Shinohara,A. and Egelman,E. (1993) Similarity of
the yeast RAD51 filament to the bacterial RecA filament. Science,
259, 1896–1899.
70. Hilario,J., Amitani,I., Baskin,R.J. and Kowalczykowski,S.C. (2009)
Direct imaging of human Rad51 nucleoprotein dynamics on
individual DNA molecules. Proc. Natl. Acad. Sci. U.S.A., 106,
361–368.
71. Di Capua,E., Engel,A., Stasiak,A. and Koller,T. (1982)
Characterization of complexes between recA protein and duplex
DNA by electron microscopy. J. Mol. Biol., 157, 87–103.
72. Thompson,S.L. and Compton,D.A. (2011) Chromosome
missegregation in human cells arises through specific types of
kinetochore-microtubule attachment errors. Proc. Natl. Acad. Sci.
U.S.A., 108, 17974–17978.
73. Bower,J.J., Karaca,G.F., Zhou,Y., Simpson,D.A., Cordeiro-Stone,M.
and Kaufmann,W.K. (2010) Topoisomerase IIalpha maintains
genomic stability through decatenation G(2) checkpoint signaling.
Oncogene, 29, 4787–4799.
74. Schlacher,K., Wu,H. and Jasin,M. (2012) A distinct replication fork
protection pathway connects Fanconi anemia tumor suppressors to
RAD51-BRCA1/2. Cancer Cell, 22, 106–116.
75. Wilhelm,T., Magdalou,I., Barascu,A., Te´cher,H., Debatisse,M. and
Lopez,B.S. (2014) Spontaneous slow replication fork progression
elicits mitosis alterations in homologous recombination-deficient
mammalian cells. Proc. Natl. Acad. Sci. U.S.A., 111, 763–768.
76. Mankouri,H.W., Huttner,D. and Hickson,I.D. (2013) How
unfinished business from S-phase affects mitosis and beyond. EMBO
J., 32, 2661–2671.
77. Hine,C.M., Seluanov,A. and Gorbunova,V. (2012) Rad51
promoter-targeted gene therapy is effective for in vivo visualization
and treatment of cancer.Mol. Ther., 20, 347–355.
78. Deakyne,J.S., Huang,F., Negri,J., Tolliday,N., Cocklin,S. and
Mazin,A.V. (2013) Analysis of the Activities of RAD54, a
SWI2/SNF2 Protein, Using a Specific Small-molecule Inhibitor. J.
Biol. Chem., 288, 31567–31580.
